The Word for Not Having Words, and Why It Doubles Cardiac Risk

There is a clinical word for the skill many high-achieving men have spent a lifetime perfecting: alexithymia. From the Greek “a” (without), “lexis” (word), and “thymos” (feeling or mood), it names the impaired ability to identify and describe your own emotional states. It is not a psychiatric disorder. In the men I see, it usually reflects the opposite of weakness: they are intelligent, analytical, and accomplished, and they have directed nearly all of their attention outward toward external problems while systematically stopping their attention from turning inward. The reason a cardiologist is writing about this is simple. The pattern is associated with how long men live.

The Mechanism

The physiology starts in the hypothalamic-pituitary-adrenal axis, the body’s primary stress-response circuit. Under normal conditions, the HPA axis runs a diurnal rhythm: cortisol peaks sharply in the first thirty minutes after waking, then falls across the day, reaching its lowest point around midnight. This slope is not incidental. It coordinates energy availability, immune activity, vascular tone, and metabolic function across the entire twenty-four-hour cycle.

Chronic emotional suppression, specifically the absence of internal emotional processing rather than simply the absence of verbal expression, keeps the HPA axis in a state of low-grade, sustained activation. The signal that would ordinarily resolve after an identifiable stressor does not resolve because the stressor is never clearly registered. The result is a flattening of the cortisol diurnal slope: the morning peak is blunted, and the evening nadir rises. In large longitudinal cohorts, this flattened slope is associated with cardiovascular mortality. Data from the Whitehall II study, a major British cohort investigated by Kumari and colleagues, found that a flatter cortisol awakening response was linked to worse long-term health outcomes, including cardiovascular events.

From the cortisol rhythm, the cascade extends downstream. Endothelial cells lining the arteries are sensitive to cortisol, to catecholamines, and to inflammatory cytokines, all of which are elevated under sustained HPA activation. Endothelial dysfunction, the earliest detectable stage of vascular disease, produces impaired vasodilation, elevated oxidative stress, and the adhesion changes that allow atherogenic particles to embed in the arterial wall. This is the same process described under every other chronic stress exposure in cardiovascular medicine; the entry point is different, but the artery-level biology is identical.

A second mechanism runs through the autonomic nervous system. Heart rate variability, the beat-to-beat fluctuation in heart rhythm governed by the balance between sympathetic and parasympathetic activity, is reduced in men with high alexithymia scores across multiple independent studies. Reduced HRV is not merely a correlate of stress; it is an independent predictor of cardiac mortality, validated in clinical populations. The chronically low-grade physiological arousal of someone who is neither processing nor resolving internal signals appears to hold HRV down through persistent sympathetic predominance.

The third mechanism is social. Alexithymic men, because they have limited access to their own internal states, rarely communicate those states to others. The result is social isolation at the level of internal experience: they may have abundant acquaintances, professional networks, and functional family structures while having essentially no one who knows their real condition. A 2015 meta-analysis by Holt-Lunstad and colleagues, covering 148 studies and 308,849 participants, found that social isolation was associated with a 29% increase in mortality, comparable in magnitude to other recognized risk factors. Emotional isolation, the specific variant alexithymia produces, may carry a similar or amplified burden, because the gap between presenting self and actual self is total.

The Cortisol Paradox: Stress Without a Signal

One of the more counterintuitive findings in alexithymia research is this: men with high alexithymia do not have blunted physiological stress responses. They have blunted subjective emotional awareness. The cortisol still rises. The sympathetic nervous system still fires. The heart rate still climbs. What is missing is the conscious registration of those states as emotional experience.

This distinction carries serious clinical implications. The normal stress cycle in a person with intact emotional awareness looks like this: stressor arrives, autonomic response begins, emotional state is registered subjectively, coping behavior is initiated (even if only internal reappraisal), resolution occurs, and the HPA axis returns toward baseline. The feedback loop depends on the registration step. When a man recognizes that he is anxious or overwhelmed, that recognition itself becomes the signal that initiates coping. He calls someone, changes his schedule, disengages, sleeps, exercises, or at minimum registers the load as real.

In men with high alexithymia, the stressor arrives and the physiological response begins, but the registration step is absent or severely attenuated. There is no internal label. There is no subjective experience that says “this is significant.” The coping behavior that would normally follow recognition does not follow, because there is no registration to trigger it. The HPA axis continues firing. The cortisol elevation persists. The catecholamine exposure continues. And the man, genuinely, does not experience this as distress. He may notice he is tired, or that something feels slightly off, but he does not identify it as a state that requires response.

The result is sustained sympathetic activation without the normal negative feedback that emotional recognition provides. Research by Lanzetta and Orr, and subsequent neuroimaging work, has shown that this is not simply emotional stoicism or willful suppression. In alexithymia, the processing gap appears to exist at the level of interoception, the brain’s monitoring of internal bodily signals, and at the level of affective labeling. The anterior insular cortex, which is centrally involved in mapping bodily states to emotional experience, shows altered activation patterns in high-alexithymia individuals. The signal from the body reaches the brain; it does not get translated into a named emotional state.

The cardiovascular consequence is chronic sympathetic predominance without the person experiencing themselves as under stress. Cortisol, in its appropriate short-term role, is adaptive. Sustained cortisol, without the feedback loop that would ordinarily attenuate it, is not. It produces the endothelial changes, the inflammatory milieu, and the metabolic disruption that the cardiovascular literature has documented across other chronic stress paradigms. The paradox is that the men most burdened by this process are often the least aware of it, which is precisely why external measures, HRV monitoring, cortisol slope measurement, standard risk factor tracking, can be informative in a way that subjective report alone cannot.

What the Evidence Shows

The term alexithymia was coined in 1973 by psychiatrists John Nemiah and Peter Sifneos, who were observing a specific clinical pattern in psychosomatic patients: detailed somatic complaints, minimal emotional vocabulary, and a near-complete absence of fantasy life. The patients Nemiah and Sifneos described had real physical illness and limited capacity to link it to psychological experience. The clinical concept remained largely in psychiatry until epidemiologists began measuring it in population samples.

The pivotal study is Kauhanen et al. 1996, published in Psychosomatic Medicine (PMID 9032717). The investigators followed a cohort of middle-aged Finnish men and assessed alexithymia using a validated self-report measure. After controlling for established cardiovascular risk factors, including smoking, blood pressure, cholesterol, and diabetes, men scoring highest on alexithymia had more than double the all-cause mortality of men scoring lowest. The effect size is comparable to hypertension. That is not a small finding embedded in a niche journal. That is a mortality signal of clinical magnitude, in a controlled prospective design, that received a fraction of the attention given to biomarker studies.

Tolmunen and colleagues extended this work in a 2010 analysis published in Heart, using a Finnish cohort study to examine incident coronary heart disease. They found alexithymia associated with a significantly elevated risk of new-onset CHD in men, again after adjustment for standard risk factors. The association held in individuals who did not have diagnosed psychiatric disorders at baseline, which addresses the confound of depression or anxiety driving both the alexithymia scores and the cardiovascular outcomes.

Lumley and colleagues have characterized the mechanism at the somatic complaint and immune function level across multiple studies. Their work shows that alexithymic individuals not only report more unexplained somatic symptoms but also show blunted immune reactivity patterns consistent with chronic low-level HPA activation, a profile that overlaps substantially with the one seen in men with elevated cardiovascular risk.

The Toronto Alexithymia Scale (TAS-20) is the standard validated screening instrument. It consists of 20 items assessing three dimensions: difficulty identifying feelings, difficulty describing feelings to others, and externally-oriented thinking. Scores above 61 indicate high alexithymia. Scores below 51 indicate low alexithymia. The scale has been validated across multiple languages and populations and is the measure used in the epidemiological studies cited above. It is not a diagnostic instrument for clinical labeling; it is a measurement tool for research and for self-understanding.

Population prevalence estimates vary by method and sample, but the range commonly cited is 8 to 17% in the general population. Several studies suggest the rate is higher in men than in women, possibly reflecting differential socialization toward internal versus external orientation, or differential development of affective vocabulary from childhood. Some investigators have proposed that the male-skewed prevalence makes alexithymia a significant, underdiscussed contributor to the male-female gap in cardiovascular mortality.

Medical Avoidance and the Compounding Problem

Alexithymia creates a second, compounding vulnerability that is distinct from the physiological mechanism: it interferes with the recognition and reporting of cardiac symptoms. Men with high alexithymia are less likely to identify chest discomfort, dyspnea, or fatigue as potentially cardiac. This is not a matter of pain threshold or stoicism. It reflects the same processing gap that applies to emotional states: internal signals from the body, whether they originate from emotional experience or from ischemic tissue, are not reliably translated into named, actionable experiences. The symptom gets filed under generalized fatigue, musculoskeletal discomfort, or stress without a clear referent, rather than under “something is wrong with my heart.”

The downstream effect is delayed presentation. Studies examining pre-hospital delay in acute myocardial infarction consistently identify symptom misattribution as a major contributor to avoidable treatment delays. For a man with high alexithymia, the misattribution is not a deliberate choice or denial. His internal monitoring system is not returning the same signal it returns in a man with a richer interoceptive vocabulary. He is not refusing to acknowledge the symptom; he does not register it as a symptom in the first place.

This overlaps with a broader pattern of healthcare engagement. Alexithymia is associated with lower engagement in preventive care and higher rates of somatization: the presentation of psychological and physiological distress as diffuse physical complaints that resist clean diagnostic framing. Men with high alexithymia are more likely to arrive in medical settings with complaints of fatigue, sleep disruption, and vague chest heaviness, all of which can represent either somatized distress or early cardiac pathology, and less likely to offer the emotional context that would help a clinician differentiate. Clinicians who are not watching for this pattern may address the biomarkers and miss the mechanism.

Social isolation adds a further layer. Alexithymia impairs emotional reciprocity: the back-and-forth exchange of internal states that sustains close relationships. Men with high alexithymia often maintain functional relationships while having almost no genuine exchange of internal experience. This is not always experienced as loneliness. It is often experienced as nothing: a flatness in the register that ought to carry meaning. The consequence is that the social support structures that would ordinarily serve as informal health surveillance, a partner noticing that something seems wrong, a close friend asking what is actually going on, are not functional in the same way. The people around the man cannot monitor what he cannot name, because he does not offer the material for them to respond to. This closes off one of the pathways through which social connection is believed to reduce cardiovascular risk.

Therapeutic approaches for alexithymia exist, though the evidence base is less robust than for the epidemiological associations. Emotion-focused therapy, somatic approaches that begin with body sensation rather than emotional vocabulary, and alexithymia-adapted versions of cognitive behavioral therapy have each shown some capacity to increase affective awareness over time. The neurobiological basis for plasticity here is not trivial: affect labeling, simply naming an emotional or physiological state out loud or in writing, has been shown in fMRI studies by Lieberman and colleagues to reduce amygdala activation and attenuate the sympathetic response associated with that state. The reduction is not dramatic, but it is measurable, and it operates through a plausible mechanism: naming creates cortical engagement with the state, which then modulates the subcortical arousal driving the physiological response. For men with high alexithymia, this is not about emotional expression as social performance. It is about building enough internal vocabulary to close the feedback loop that chronic physiological activation has been running open.

Physical activity is separately relevant and may offer a pathway that does not require vocabulary building as an entry point. Regular aerobic exercise increases HRV, which is both a marker of autonomic balance and, in prospective data, a predictor of cardiovascular outcomes. Several investigators have noted that structured physical activity may serve a particular function for alexithymic men because it creates a reliable domain of interoceptive feedback, effort, fatigue, cardiorespiratory sensation, that is less emotionally loaded than the internal states alexithymia disrupts. Whether exercise addresses the alexithymia construct directly or simply improves the downstream biological profile in a way that partially bypasses the mechanism is not established. The practical implication is the same: regular structured exercise is indicated, and for alexithymic men, its benefits may extend beyond the standard cardiovascular pathways.

What to Do This Week

1. Score yourself on the TAS-20. The Toronto Alexithymia Scale is freely available online through academic sources. A score above 61 puts you in the high range. This is not a diagnosis; it is a calibration. Men who score high often recognize the pattern immediately in the item content, which is itself informative.

2. Build a five-word internal vocabulary. The goal is not emotional fluency as a social performance. The goal is functional internal monitoring. Pick five words that describe distinct states you actually experience: fatigued, irritable, unsettled, stretched, relieved. Use at least one of them internally, once per day, applied to your actual current state. This is a monitoring practice, not a therapy exercise.

3. Identify one person who knows your real condition. Not the performance you present at work or in social contexts. Your real condition: what you are actually carrying, how depleted or stressed you actually are. If no such person exists, that is the data. Social isolation at the internal level is one of the specific mechanisms connecting alexithymia to mortality outcomes.

4. Track your resting HRV for two weeks. Consumer devices with optical HRV monitoring (Garmin, Apple Watch, Whoop, Oura) give a directionally valid signal. A chronically low resting HRV, combined with high alexithymia scores, suggests the autonomic profile described in the mechanism section is already active. This gives you a biological correlate to watch as you change behavior.

5. If the pattern is longstanding, treat it like any other modifiable risk factor. A clinician who understands alexithymia, typically someone with training in psychosomatic medicine or health psychology, can help build the internal monitoring capacity that went quiet. This is not a luxury. For a man with a flattened cortisol profile and high TAS-20 scores, addressing alexithymia has a similar intervention logic to addressing hypertension: it modifies a documented biological pathway toward a bad outcome.

The Kauhanen et al. data from 1996 showed a more-than-twofold mortality difference between the highest and lowest alexithymia groups in middle-aged men. That number has not been widely absorbed into preventive cardiology practice, in part because the intervention is behavioral rather than pharmacological. But the magnitude of the finding demands the same seriousness given to a systolic blood pressure of 160. The internal world is not incidental to the cardiovascular system. For a significant fraction of high-achieving men, learning to monitor it may be the intervention with the most unaddressed yield on the table.